journal article·2013-10-09

Trafficking of Gold Nanorods in Breast Cancer Cells: Uptake, Lysosome Maturation, and Elimination

Weiqi Zhang, Yinglu Ji, Xiaochun Wu, Haiyan Xu

Publisher page

Abstract

Gold nanorods (AuNRs) have been largely investigated driven by their promising potentials in drug delivery, imaging, and photodynamic therapy because of their distinctive physicochemical properties. It is widely known that AuNRs can be taken up by different cells, however, the trafficking of the nanorods in cells are less known. In this work, the behaviors and fate of AuNRs in the human breast cancer cell line MDA-MB-231 were intensively probed by transmission electron microscopy (TEM) with detailed time resolution, together with induced couple plasmon mass spectroscopy (ICP-MS), confocal microscopy, Western blot, and cell viability assay. We reveal that AuNRs enter the classic lysosome maturation through endocytosis and are sequestered in the vesicular system even during cell division. AuNRs can escape from the lysosomes occasionally and the escaped AuNRs are recycled back into the lysosomal system through cytoprotective autophagy. The dilution of AuNRs in cells is mainly attributed to the cell division rather than exocytosis, because expelled AuNRs can be re-endocytosed by the cells. The feature of vesicular restriction guarantees other organelles such as mitochondria and nucleus are exempted from the direct exposure to AuNRs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, P. R. China

CAS Key Laboratory of Standardization and Measurement for Nanotechnology, National Center for Nanoscience and Technology, Beijing 100190, P. R. China

References (42)

Show source-provided references
1. Cobley C. M. · Chem. Soc. Rev. · 2011 · 40 · 4410.1039/B821763G ↗
2. Alkilany A. M. · Adv. Drug Delivery Rev. · 2012 · 64 · 19010.1016/j.addr.2011.03.005 ↗
3. Oyelere A. K. · Bioconjugate Chem. · 2007 · 18 · 149010.1021/bc070132i ↗
4. Chen J. · ACS Nano · 2009 · 3 · 407110.1021/nn900743v ↗
5. Chithrani B. D. · Nano Lett. · 2007 · 7 · 154210.1021/nl070363y ↗
6. Zhang W. · Nanoscale · 2011 · 3 · 392310.1039/c1nr10573f ↗
7. Pangarkar C. · J. Controlled Release · 2012 · 162 · 7610.1016/j.jconrel.2012.05.022 ↗
8. Dominska M. · J. Cell Sci. · 2010 · 123 · 118310.1242/jcs.066399 ↗
9. Taylor A. · Chem. Soc. Rev. · 2012 · 41 · 270710.1039/c2cs35031a ↗
10. Alkilany A. M. · Small · 2009 · 5 · 70110.1002/smll.200801546 ↗
11. Parab J. H. · J. Phys. Chem. C · 2009 · 113 · 757410.1021/jp9000169 ↗
12. Qiu Y. · Biomaterials · 2010 · 31 · 760610.1016/j.biomaterials.2010.06.051 ↗
13. Rosman C. · Small · 2012 · 8 · 368310.1002/smll.201200853 ↗
14. Li J. L. · Biomaterials · 2010 · 31 · 949210.1016/j.biomaterials.2010.08.068 ↗
15. Jang B. · Theranostics · 2012 · 2 · 19010.7150/thno.3478 ↗
16. Harding C. · J. Cell Biol. · 1983 · 97 · 32910.1083/jcb.97.2.329 ↗
17. Kleijmeer M. J. · J. Cell Biol. · 1997 · 139 · 63910.1083/jcb.139.3.639 ↗
18. Huotari J. · EMBO J. · 2011 · 30 · 348110.1038/emboj.2011.286 ↗
19. Chang J. P. · Cancer Res. · 1968 · 28 · 521
20. Feng L. · Chem.—Eur. J. · 2008 · 14 · 976410.1002/chem.200800544 ↗
21. Firat-Karalar E. N. · Curr. Opin. Cell Biol. · 2011 · 23 · 410.1016/j.ceb.2010.10.007 ↗
22. Sakai J. · Immunity · 2012 · 37 · 103710.1016/j.immuni.2012.08.017 ↗
23. Krishna, V. S.InComprehensive Biotechnology II: Including Cell Biology, Genetics Microbiology and Immunology,1st ed.New Age International:New Delhi, India, 2006; p42–91.
24. Conner S. D. · Nature · 2003 · 422 · 3710.1038/nature01451 ↗
25. Canton I. · Chem. Soc. Rev. · 2012 · 41 · 271810.1039/c2cs15309b ↗
26. Wang L. · Nano Lett. · 2011 · 11 · 77210.1021/nl103992v ↗
27. Luzio J. P. · Nat. Rev. Mol. Cell Biol. · 2007 · 8 · 62210.1038/nrm2217 ↗
28. Zhang W. · PLoS ONE · 2012 · 7 · e3195710.1371/journal.pone.0031957 ↗
29. Shi X. · Nat. Nanotechnol. · 2011 · 6 · 71410.1038/nnano.2011.151 ↗
30. Li Y. · Biomaterials · 2012 · 33 · 496510.1016/j.biomaterials.2012.03.044 ↗
31. Longatti A. · Cell Death Differ. · 2009 · 16 · 95610.1038/cdd.2009.39 ↗
32. Fairn G. D. · Trends Immunol. · 2012 · 33 · 39710.1016/j.it.2012.03.003 ↗
33. Nakagawa I. · Science · 2004 · 306 · 103710.1126/science.1103966 ↗
34. Kimura S. · Methods Enzymol. · 2009 · 452 · 110.1016/S0076-6879(08)03601-X ↗
35. Mizushima N. · Cell · 2010 · 140 · 31310.1016/j.cell.2010.01.028 ↗
36. Ma X. · ACS Nano · 2011 · 5 · 862910.1021/nn202155y ↗
37. Stern S. T. · Part. Fibre Toxicol. · 2012 · 9 · 2010.1186/1743-8977-9-20 ↗
38. Zhao Y. · Small · 2013 · 9 · 38710.1002/smll.201201363 ↗
39. Hussain S. · ACS Nano · 2012 · 6 · 582010.1021/nn302235u ↗
40. Setyawati M. I. · Nat. Commun. · 2013 · 4 · 167310.1038/ncomms2655 ↗
41. Youssef G. · Dev. Biol. · 2013 · 380 · 27410.1016/j.ydbio.2013.04.034 ↗
42. Bergeland T. · Curr. Biol. · 2001 · 11 · 64410.1016/S0960-9822(01)00177-4 ↗